Trailing-twelve-month (TTM) revenue is $215.85 Million with a year-over-year growth of +3.95%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $53,134,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q4 FY2025Period ended 2025-12-31 | $58,855,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-11 |
| Q1 FY2026Period ended 2026-03-31 | $48,540,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-13 |
| Q2 FY2026Period ended 2026-06-30 | $55,319,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-12 |
| TTM revenue | $215,848,000 |
Current P/S: $852,433,074 market capitalization ÷ $215,848,000 TTM revenue = 3.95x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T17:14:57.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $55.32M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:17:06.773Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20182018-12-31 · USD | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Product | $172,000 | N/A | $25M | $161M | $148M | $156M |
| Service | N/A | $6M | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Asia Pacific | $14M | $23M | $24M | $22M | $22M | $22M |
| EMEA | $46M | $79M | $93M | $61M |
$215.85M
$215.85 Million
+3.95%
vs. $207.65M a year ago (TTM)
+1.49%
5 Year compound annual growth rate
1 Year
+3.95%
3 Year
(2.66%)
5 Year
+1.49%
10 Year
+8.73%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $208.20M | +$4.38M | +2.15% |
| 2024 | $203.82M | ($15.96M) | (7.26%) |
| 2023 | $219.79M | ($51.73M) | (19.05%) |
| 2022 | $271.52M | ($50.49M) | (15.68%) |
| 2021 | $322.01M | +$128.68M | +66.56% |
| 2020 |
TTM Growth
+3.95%
3-Year CAGR
(2.66%)
5-Year CAGR
+1.49%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T17:17:06.773Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $56M |
| $52M |
| $52M |
| ISRAEL | N/A | N/A | N/A | N/A | N/A | $363,000 |
|---|
| Other Countries Member | N/A | N/A | $15M | $14M | N/A | N/A |
|---|
| OtherCountriesMember | $9M | $9M | N/A | N/A | N/A | N/A |
|---|
| TotalRevenueCountriesMember | $193M | $322M | N/A | N/A | N/A | N/A |
|---|
| UNITED STATES | N/A | $211M | $139M | $124M | $115M | $122M |
|---|
| $193.33M |
| +$13.46M |
| +7.49% |
| 2019 | $179.87M | +$37.49M | +26.33% |
| 2018 | $142.37M | +$28.29M | +24.79% |
| 2017 | $114.09M | +$5.39M | +4.96% |
| 2016 | $108.69M | +$22.29M | +25.80% |
